NEW YORK--(BUSINESS WIRE)--
(NASDAQ:MDSO), the leading global provider of cloud-based solutions for
clinical research in life sciences, today announced that it will release
its fourth quarter 2016 financial results before the open of the market
on Thursday, February 9, 2017. Tarek Sherif, chief executive officer,
and Rouven Bergmann, chief financial officer, will also hold a
conference call at 8:00 a.m. ET for investors and analysts to discuss
the Company's results and business outlook.
To participate by telephone, domestic participants may dial
1-877-303-2528 and international participants may dial 1-847-829-0023.
Those interested in participating in the conference call should dial in
at least 10 minutes prior to the call to register.
Participants can also join the call via a simultaneous live audio
webcast, which will be made available on the "Investor" section of
Medidata's website, http://investor.mdsol.com.
A replay of the conference call can be accessed through February 23,
2017, by dialing 1-800-585-8367 domestically or 1-404-537-3406
internationally, with the passcode 52493043. An archive of the call will
also be hosted on the "Investor" section of Medidata's website, http://investor.mdsol.com,
for a limited period of time.
is reinventing global drug development by creating the industry's
leading cloud-based solutions for clinical research. Through our
advanced applications and intelligent data analytics, Medidata helps
advance the scientific goals of life sciences customers worldwide,
including nearly 800 global pharmaceutical companies, innovative
biotech, diagnostic and device firms, leading academic medical centers,
and contract research organizations.
The Medidata Clinical Cloud® brings a new level of quality
and efficiency to clinical trials that empower our customers to make
more informed decisions earlier and faster. Our unparalleled clinical
trial data assets provide deep insights that pave the way for future
growth. The Medidata Clinical Cloud is the primary technology solution
powering clinical trials for 17 of the world's top 25 global
pharmaceutical companies, from study design and planning through
execution, management and reporting. companies, from study design and
planning through execution, management and reporting.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170126005261/en/
Source: Medidata Solutions
News Provided by Acquire Media